340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties (US Health Resources and Services Administration Regulation) (HRSA) (2018 Edition‪)‬

The Law Library presents the complete text of the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties (US Health Resources and Services Administration Regulation) (HRSA) (2018 Edition).
Updated as of May 29, 2018

The Health Resources and Services Administration (HRSA) administers section 340B of the Public Health Service Act (PHSA), referred to as the “340B Drug Pricing Program” or the “340B Program.” This final rule will apply to all drug manufacturers that are required to make their drugs available to covered entities under the 340B Program. This final rule sets forth the calculation of the 340B ceiling price and application of civil monetary penalties (CMPs).

This ebook contains:
- The complete text of the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties (US Health Resources and Services Administration Regulation) (HRSA) (2018 Edition)
- A dynamic table of content linking to each section
- A table of contents in introduction presenting a general overview of the structure